IL-33 Participates in the Development of Esophageal Adenocarcinoma

IL-33 Participates in the Development of Esophageal Adenocarcinoma

Background: The progression from chronic gastroesophageal reflux disease (GERD) to Barrett esophagus (BE) and esophageal adenocarcinoma (EAC) is an inflammatory-driven neoplastic change. Interleukin-33 (IL-33) has identified as a crucial factor in several inflammatory disorders and malignancies.Meth...

Full description

Bibliographic Details
Main Authors: Jia Liu, Lei Liu, Yang Su, Yi Wang, Yuchun Zhu, Xiaobin Sun, Yuanbiao Guo, Jing Shan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Pathology and Oncology Research
Subjects:
EMT
esophageal adenocarcinoma
interleukin-33
ST2
EAC rat model
Online Access:https://www.por-journal.com/articles/10.3389/pore.2022.1610474/full

Internet

https://www.por-journal.com/articles/10.3389/pore.2022.1610474/full

Similar Items